Revolve Surgical Wins FDA Clearance for Surgical Robot

Revolve Surgical recently announced that it received FDA 510(k) clearance for its surgical robot platform. Their first-in-class, zero-footprint surgical platform provides robotic assistance to augment surgeons performing soft tissue procedures. Their table-mounted system can integrate into existing clinical workflows. Backed by Y Combinator, Revolve states that its ultimate goal is to enable physical AI in operating rooms at scale.

Revolve Surgical is an OBIO® member and an alumnus of our CAAP® program.